Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
Ontology highlight
ABSTRACT: The tumour microenvironment (TME) plays a pivotal role in tumour fate determination. The TME acts together with the genetic material of tumour cells to determine their initiation, metastasis and drug resistance. Stromal cells in the TME promote the growth and metastasis of tumour cells by secreting soluble molecules or exosomes. The abnormal microenvironment reduces immune surveillance and tumour killing. The TME causes low anti-tumour drug penetration and reactivity and high drug resistance. Tumour angiogenesis and microenvironmental hypoxia limit the drug concentration within the TME and enhance the stemness of tumour cells. Therefore, modifying the TME to effectively attack tumour cells could represent a comprehensive and effective anti-tumour strategy. Normal cells, such as stem cells
SUBMITTER: Cheng YQ
PROVIDER: S-EPMC7445401 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA